NervGen Pharma Corp. (TSXV:NGEN)
Canada
· Delayed Price · Currency is CAD 5.80
+0.03 (0.52%)
At close: Dec 5, 2025
NervGen Pharma Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 11.36 | 17.27 | 11.66 | 22.45 | 16.93 | 5.6 | Upgrade
|
| Cash & Short-Term Investments | 11.36 | 17.27 | 11.66 | 22.45 | 16.93 | 5.6 | Upgrade
|
| Cash Growth | -45.91% | 48.10% | -48.07% | 32.62% | 202.38% | 36.34% | Upgrade
|
| Accounts Receivable | 0.03 | 0.1 | - | - | - | - | Upgrade
|
| Other Receivables | 0.34 | 0.42 | 0.25 | 0.03 | 0.06 | 0.06 | Upgrade
|
| Receivables | 0.38 | 0.51 | 0.25 | 0.03 | 0.06 | 0.06 | Upgrade
|
| Prepaid Expenses | 0.22 | 0.18 | 0.11 | 0.08 | 0.07 | 0.05 | Upgrade
|
| Other Current Assets | 0.69 | 1.05 | 0.5 | 0.59 | 0.36 | 0.49 | Upgrade
|
| Total Current Assets | 12.65 | 19.01 | 12.52 | 23.15 | 17.42 | 6.2 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.2 | 0.3 | 0 | 0 | Upgrade
|
| Other Intangible Assets | 0.42 | 0.46 | 0.52 | 0.43 | 0.47 | 0.47 | Upgrade
|
| Long-Term Accounts Receivable | - | 0.01 | - | - | - | - | Upgrade
|
| Total Assets | 13.08 | 19.49 | 13.24 | 23.88 | 17.9 | 6.68 | Upgrade
|
| Accounts Payable | - | - | 3.32 | 2 | 0.35 | 0.17 | Upgrade
|
| Accrued Expenses | 5.41 | 4.94 | - | 1.4 | 0.73 | 0.58 | Upgrade
|
| Current Portion of Leases | 0.03 | 0.1 | 0.09 | 0.09 | - | - | Upgrade
|
| Other Current Liabilities | 10.58 | 11.86 | 11.73 | 6.73 | - | - | Upgrade
|
| Total Current Liabilities | 16.02 | 16.9 | 15.14 | 10.22 | 1.08 | 0.76 | Upgrade
|
| Long-Term Leases | - | 0.01 | 0.11 | 0.2 | - | - | Upgrade
|
| Total Liabilities | 16.02 | 16.91 | 15.25 | 10.41 | 1.08 | 0.76 | Upgrade
|
| Common Stock | 90.48 | 81.1 | 58.93 | 57.41 | 42.4 | 22.95 | Upgrade
|
| Retained Earnings | -119.85 | -102.16 | -78.15 | -55.77 | -35.05 | -22.32 | Upgrade
|
| Comprehensive Income & Other | 26.43 | 23.64 | 17.21 | 11.82 | 9.46 | 5.3 | Upgrade
|
| Shareholders' Equity | -2.94 | 2.58 | -2.01 | 13.46 | 16.82 | 5.92 | Upgrade
|
| Total Liabilities & Equity | 13.08 | 19.49 | 13.24 | 23.88 | 17.9 | 6.68 | Upgrade
|
| Total Debt | 0.03 | 0.11 | 0.2 | 0.28 | - | - | Upgrade
|
| Net Cash (Debt) | 11.33 | 17.16 | 11.46 | 22.17 | 16.93 | 5.6 | Upgrade
|
| Net Cash Growth | -45.73% | 49.72% | -48.29% | 30.95% | 202.38% | 36.34% | Upgrade
|
| Net Cash Per Share | 0.16 | 0.25 | 0.19 | 0.42 | 0.43 | 0.17 | Upgrade
|
| Filing Date Shares Outstanding | 78.34 | 70.99 | 69.93 | 59.13 | 46.23 | 35.86 | Upgrade
|
| Total Common Shares Outstanding | 73.41 | 70.33 | 59.61 | 58.78 | 46.19 | 35.17 | Upgrade
|
| Working Capital | -3.36 | 2.11 | -2.62 | 12.93 | 16.34 | 5.45 | Upgrade
|
| Book Value Per Share | -0.04 | 0.04 | -0.03 | 0.23 | 0.36 | 0.17 | Upgrade
|
| Tangible Book Value | -3.36 | 2.11 | -2.53 | 13.03 | 16.35 | 5.45 | Upgrade
|
| Tangible Book Value Per Share | -0.05 | 0.03 | -0.04 | 0.22 | 0.35 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.